AMENDMENT NO. 3 TO TRANSACTION AGREEMENTTransaction Agreement • January 22nd, 2018 • Avista Healthcare Public Acquisition Corp. • Services-commercial physical & biological research
This AMENDMENT NO. 3 TO TRANSACTION AGREEMENT, dated as of January 21, 2018 (this “Amendment”), is made by and among Envigo International Holdings, Inc., a Delaware corporation (the “Company”), Avista Healthcare Public Acquisition Corp., a Cayman Islands exempted company (“Parent”), Avista Healthcare Merger Sub, Inc., a Delaware corporation and a direct, wholly-owned subsidiary of Parent (“Merger Sub”), Avista Healthcare NewCo, LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of Parent (“NewCo”) and Jermyn Street Associates LLC, solely in its capacity as Shareholder Representative (the “Shareholder Representative”). Capitalized terms used herein but not specifically defined herein shall have the meanings ascribed to such terms in the Transaction Agreement (as defined below).
January 21, 2018Letter Agreement • January 22nd, 2018 • Avista Healthcare Public Acquisition Corp. • Services-commercial physical & biological research
